Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré 2018-02-14T11:46:54+00:00
Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré

Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré

IRBLleida is a non-profit research organization created in 2004 as a result of a collaboration agreement between the Catalan Health Institute (ICS), Dr Pifarré Foundation and the University of Lleida (UdL), to boost synergies between basic, clinical and epidemiological research carried out in the region of Lleida with the aim of improving clinical practice for the benefit of the entire population.

The institute is an autonomous legal body which brings together researchers from the Faculty of Medicine of UdL, Faculty of Nursing of UdL, the University Hospital Arnau de Vilanova (HUAV), Regional Services of the Ministry of Health-ICS Lleida, and Gestió de Serveis Sanitaris (GSS) in a unique and single research institution in the region.

At the present, IRBLleida accounts more than 350 researchers working in five major research areas in the fields of Cancer Research (clinical and molecular viewpoints), Systems Biology, Neurosciences (Neurodegeneration and Developmental Neurobiology), Ageing and Age-related diseases (diabetes, cardiovascular disease, cardiometabolic syndrome, sleep apnea, nursing cares), Pharmacoepidemiology and Nutrition.

For more information, visit www.irblleida.org

Role in the project

As experts in Ageing and Age-related diseases (diabetes, cardiovascular disease, cardiometabolic syndrome, sleep apnoea, nursing cares), Biomedical Research Institute of Lleida (IRBLleida) is the leader of WP2 of the project, designing the basis to obtain a chronic complex patient (CCP) health care model adaptable to different environments, societies and health care resources. A model based on 4P medicine (predictive, preventive, personalized and participatory) with five components: screening for CCP; risk stratification for hospital admission; mapping of CCPs and its clinical and social circumstances to plan health care; proactive and planned interventions; and surveillance for clinical a social status changes in CCPs.

IRBLleida is also working with EURECAT in the customization, integration and deployment of the CONNECARE system in Catalonia (from Hospital Arnau de Vilanova) and participates in the development and evaluation of the clinical studies.

The Institut de Recerca Biomèdica de Lleida Fundació Dr Pifarré team

Gerard Torres, PhD. is a physician graduated in in 1992 by the University of Barcelona and got the internal medicine specialist graduation in General Hospital of Hospitalet in 1998. He holds two masters, in Cardiology by the University Miguel Hernandez of Elche and in chronic diseases by the University of Barcelona, and a PhD. degree in medicine by the University of Lleida.

Currently, he combines his duties and tasks as Head of the Internal Medicine Service of the University Hospital of Santa Maria in Lleida with his work as senior researcher in the Group of Translational Research in Respiratory Medicine (TRRM) at the IRBLleida.

In 2016, he assumed the role of main researcher of the EU project CONNECARE (H2020) at IRBLleida. In addition, he is currently participating in other projects of the TRRM such as SARAH study and ILERVAS project. Beyond this, he is directing a doctoral thesis.

His research interests are on, “Sleep Apnoea” and hypertension. He has been granted two times by the Catalan Society of Hypertension, two times by the Spanish FIS research fund and one time by the research grant of “La Marató” of TV3 (Catalonia). He has authored several articles in prestigious international journals of the field, including “European Respiratory Journal” and “CHEST”.

Ferran Barbé MD, PhD. received his degree in medicine in 1985 and his PhD. degree in 1999 from the University of Barcelona. He followed the training programme in Respiratory Medicine at the Hospital de Bellvitge in Barcelona. In 1992 he got the Diplome D’Universite in sleep physiology by the University Rene Descartes in Paris. He was the director during 14 years of the sleep unit at the Son Dureta University Hospital in Palma de Mallorca.

In 2005, he moved to Lleida as a head of the Respiratory Department at the Arnau de Vilanova University Hospital and Professor of Respiratory Medicine at the University of Lleida. Since 2006 he is also Professor of Respiratory Medicine at the School of Medicine of the University of Barcelona. In 2014, Dr. Barbé got the position of Director of Biomedical Research Networking Center Consortium for Respiratory Diseases (CIBERES). He is also the Head of the TRRM Group in the IRBLleida.

The work of Dr. Barbé is focused on sleep apnoea and cardiovascular diseases. His research interest is aimed to better understanding the pathogenesis of cardiovascular consequences in sleep apnoea patients and to evaluate new diagnostic and therapeutic options in such patients. He has published 200 papers in peer-reviewed journals, which received over 5200 citations. His h-index is 40.

Jordi de Batlle, PhD. degree in Health and Life Sciences (Epidemiology) by the Pompeu Fabra University in Barcelona where he studied the measure and effect of diet in chronic obstructive pulmonary disease, obtaining the Cum Laude distinction.

He was granted twice by the Marie Skłodowska-Curie actions program. The first, to conduct a 2-year project in the Nutritional Epidemiology section of the International Agency for Research on Cancer (IARC-WHO), Lyon, France, focused on the relationships between vegetal nutrients with breast cancer, and meat products with colorectal cancer. The second, to conduct a 2-year project in the TRRM group, at the IRBLleida, focused on the management of patients with suspected obstructive sleep apnoea in primary care units compared with sleep units. Both of them were evaluated as very successful. In 2016 he was awarded with a Research Contract from the Catalan government: Pla estratègic de recerca i innovació en salut 2016-2020 (PERIS-2016).

Currently, he is a senior research fellow in the TRRM group. In 2016, he assumed the co-leadership of the WP2 of the EU project CONNECARE (H2020). He is also participating in several projects of the TRRM (ISAACC, MyOSA, BIG DATA, and ESCA, among others) and co-directing 3 doctoral theses.

His research interests are to understand and study different aspects of chronic respiratory diseases, Sleep Apnoea, nutritional epidemiology and community-based management of chronic diseases. In those topics, he has authored more than 50 peer-reviewed research articles in international journals; including first authorship of articles in prestigious journals as Am J Respir Crit Care Med, J Natl Cancer Inst, Eur J Nutr, and Allergy.

Manuel Sánchez de la Torre, PhD. received his degree in biology in 2003 by the University of Jaén and his PhD. degree in biology in 2007 by the University of Lleida. His thesis was focused in the evaluation of the genetic variability of the host related to the infection with HIV-1. After completing his PhD, he accepted a position as research coordinator in the TRRM group at the IRBLleida and Biomedical Research Networking Center Consortium for Respiratory Diseases (CIBERES, Madrid, Spain). Since 2008, Dr. Sánchez de la Torre is an Associate Professor at the University of Lleida. In 2015, he became National Coordination in Sleep Research in CIBERES.

He also performed a research fellowship at the University of Chicago. During his fellowship Dr. Sánchez de la Torre pioneered the precision medicine in sleep apnoea and hypertension, developing a micro-RNA based system that predicts clinical response to sleep apnoea treatment.

He obtained the Best original publication in Sleep Society Award in 2015, the Young Researcher of Spanish Respiratory Society (SEPAR) Award in 2016, the Young Researcher Award of AstraZeneca Foundation in 2016, and the Young Researcher Award of the American Thoracic Society in 2016.

His scientific interest is focused in sleep apnoea. His research aims to achieve a better understanding of the cardiovascular consequences for sleep apnoea patients, to develop new diagnostic and therapeutic options in such patients, and implementing precision medicine strategies for them. Dr. Sánchez de la Torre has leaded as principal researcher 8 research projects granted in competitive calls at national and international level. He is author of more than 50 papers published in peer-reviewed journals; these papers have received over 900 citations. His H-index is 15 and he is Junior Editor of European Respiratory Journal.